176 related articles for article (PubMed ID: 22688145)
1. Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.
Parkman HP; Mishra A; Jacobs M; Pathikonda M; Sachdeva P; Gaughan J; Krynetskiy E
J Clin Gastroenterol; 2012 Jul; 46(6):494-503. PubMed ID: 22688145
[TBL] [Abstract][Full Text] [Related]
2. Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.
Parkman HP; Jacobs MR; Mishra A; Hurdle JA; Sachdeva P; Gaughan JP; Krynetskiy E
Dig Dis Sci; 2011 Jan; 56(1):115-24. PubMed ID: 21063774
[TBL] [Abstract][Full Text] [Related]
3. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
4. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J
Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548
[TBL] [Abstract][Full Text] [Related]
5. Metoclopramide improves gastric but not gallbladder emptying in cardiac surgery patients with early intragastric enteral feeding: randomized controlled trial.
Sustić A; Zelić M; Protić A; Zupan Z; Simić O; Desa K
Croat Med J; 2005 Apr; 46(2):239-44. PubMed ID: 15849845
[TBL] [Abstract][Full Text] [Related]
6. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
[TBL] [Abstract][Full Text] [Related]
7. Review article: The diagnosis and management of gastroparesis.
Haans JJ; Masclee AA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
[TBL] [Abstract][Full Text] [Related]
8. Understanding diabetic gastroparesis: a case study.
Tonzi MK; Fain JA
Gastroenterol Nurs; 2002; 25(4):154-60; quiz 161-2. PubMed ID: 12195149
[TBL] [Abstract][Full Text] [Related]
9. Disparate response to metoclopramide therapy for gastric feeding intolerance in trauma patients with and without traumatic brain injury.
Dickerson RN; Mitchell JN; Morgan LM; Maish GO; Croce MA; Minard G; Brown RO
JPEN J Parenter Enteral Nutr; 2009; 33(6):646-55. PubMed ID: 19892902
[TBL] [Abstract][Full Text] [Related]
10. Metoclopramide for the treatment of diabetic gastroparesis.
Shakhatreh M; Jehangir A; Malik Z; Parkman HP
Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):711-721. PubMed ID: 31314613
[No Abstract] [Full Text] [Related]
11. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
McCallum RW; Cynshi O;
Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet.
Parkman HP; Carlson MR; Gonyer D
Neurogastroenterol Motil; 2014 Apr; 26(4):521-8. PubMed ID: 24372829
[TBL] [Abstract][Full Text] [Related]
13. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown CK; Khanderia U
Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
[TBL] [Abstract][Full Text] [Related]
14. Warnings on metoclopramide treatment.
Bernstein R
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1138; author reply 1138-9. PubMed ID: 19426834
[No Abstract] [Full Text] [Related]
15. Metoclopramide and unintended weight gain.
Sansone RA; Sansone LA
Int J Eat Disord; 2003 Sep; 34(2):265-8. PubMed ID: 12898564
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
Parkman HP; Carlson MR; Gonyer D
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
[TBL] [Abstract][Full Text] [Related]
17. Gastric emptying in infants: response to metoclopramide depends on the underlying condition.
Hyman PE; Abrams CE; Dubois A
J Pediatr Gastroenterol Nutr; 1988; 7(2):181-4. PubMed ID: 3351700
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
McCallum RW; Valenzuela G; Polepalle S; Spyker D
J Pharmacol Exp Ther; 1991 Jul; 258(1):136-42. PubMed ID: 2072291
[TBL] [Abstract][Full Text] [Related]
19. Metoclopramide suppositories in the treatment of diabetic gastroparesis.
Trapnell BC; Mavko LE; Birskovich LM; Falko JM
Arch Intern Med; 1986 Nov; 146(11):2278-9. PubMed ID: 3778059
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
